wet AMD - Classic CNVM mild vision loss
|
|
80 year old female She did not notice a problem but then when she saw you her vision in the right eye was hazy. The left eye was being watched because of eyelid herpes. The right eye has always been the weaker eye. She has not noticed a vision change in the right eye.
Shingles post-herpetic neuralgia over left eye for 2 years
VA OD: Dcc20/40+1 NccJ3
VA OS: Dcc20/25-2 NccJ1-1
IOP: TP: OD:17 OS:21
Anterior segment unremarkable (PCIOLs)
Vision improved to 20/25 after two Avastin shots and at 1 year she is getting treatment every 2 months
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 29080 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 26480 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 25780 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 28080 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 26980 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 25580 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 28580 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 26280 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 26180 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 26480 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 25580 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 27180 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 25880 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 25880 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 25380 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 29180 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 29580 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 27980 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 27580 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 26380 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 29480 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 24580 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 23080 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 27680 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 24880 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
|
|
|
|
|
80 year old female She did not notice a problem but then when she saw you her vision in the right eye was hazy. The left eye was being watched because of eyelid herpes. The right eye has always been the weaker eye. She has not noticed a vision change in the right eye.
Shingles post-herpetic neuralgia over left eye for 2 years
VA OD: Dcc20/40+1 NccJ3
VA OS: Dcc20/25-2 NccJ1-1
IOP: TP: OD:17 OS:21
Anterior segment unremarkable (PCIOLs)
Vision improved to 20/25 after two Avastin shots and at 1 year she is getting treatment every 2 months
